AZ/Merck & Co' s Lynparza Gets US Approval For Prostate Cancer

Days After Green Light For Clovis's Rival PARP

 
• By Kevin Grogan
  
targets
Lynparza now approved for four tumor types • Source: Shutterstock

More from Anticancer

More from Therapy Areas